-The Hindu The Supreme Court has denied Novartis a patent for its anti-cancer drug Gleevec. This leaves the door open for Indian pharmaceutical companies to produce their own versions of the drug. Since these are sold at roughly one tenth of the patented brand price, for thousands of cancer patients it means the difference between medicine and no medicine at all. It is not just cancer patients that will benefit, but...

-The Hindu   "It deserves to be thrown into the dustbin" The Supreme Court on Thursday rejected the magisterial probe report on the Tarn Taran incident, in which a girl and her father were beaten up by the Punjab police, as it justified the attack on the duo. A Bench of Justices G.S. Singhvi and Kurian Joseph told Additional Solicitor-General Siddharth Luthra, appearing for the Punjab government, "the report does not have the value...

-The Indian Express A committee appointed by the Supreme Court to probe six cases of alleged extra-judicial killings in Manipur informed the court on Thursday that all the encounters were fake. The committee, comprising retired judge Santosh Hegde, former chief election commissioner J M Lyngdoh and former Karnataka police chief A K Singh, held that all the seven victims, including a 12-year-old boy, did not have any criminal background and had not...

-Live Mint Reimbursing schools that reserve 25% seats for underprivileged children may end up costing the govt about Rs.16,000 cr The central government is faced with the prospect of a large bill to pay for the implementation of one of the key elements of the right to education (RTE) legislation-reimbursing private schools that reserved 25% of their seats for underprivileged children-even as the 31 March deadline for most of the law's other...

-The Indian Express India is no insecure dictatorship junking international obligations for cheap populism. The highest court of the world's largest democracy has made a nuanced distinction between real innovation and marketing gimmickry. Yet, the Swiss pharmaceutical giant Novartis's response to the recent Supreme Court verdict in Novartis vs Union of India has been imperial in tone. The judgment "discourages innovative drug discovery", it claimed. It accused Indian law of lagging...